J. B. Chemicals & Pharmaceuticals (NSEI:JBCHEPHARM) - 주가, 뉴스 및 분석

JBCHEPHARM 주식 개요

J. B. 화학 및 제약 회사는 인도 및 국제적으로 의약품 제제, 약초 치료제 및 활성 제약 성분(API)을 제조 및 판매합니다. 자세한 내용

JBCHEPHARM 기본 분석
눈송이 점수
가치 평가	2/6
미래 성장	4/6
과거 실적	5/6
재무 상태	6/6
배당금	4/6

보상

수익은 매년 19.41% 증가할 것으로 예상됩니다.

지난 1년간 수익이 25.6% 증가했습니다.

분석가들은 주가가 25.3% 상승할 것이라는 데 동의합니다.

위험 분석

지난 3개월간 상당한 내부자 매도

불안정한 배당 실적

J. B. Chemicals & Pharmaceuticals Limited 경쟁사

Gland Pharma

NSEI:GLAND

₹286.3b

Ajanta Pharma

NSEI:AJANTPHARM

₹377.5b

Ipca Laboratories

NSEI:IPCALAB

₹391.4b

Neuland Laboratories

BSE:524558

₹214.1b

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 J. B. Chemicals & Pharmaceuticals
과거 주가
현재 주가	₹1,735.30
52주 최고치	₹2,030.00
52주 최저치	₹1,412.55
베타	-0.016
11개월 변경	-7.82%
3개월 변경 사항	-11.18%
1년 변경 사항	18.82%
33년 변화	114.90%
5년 변화	760.66%
IPO 이후 변화	2,197.65%

최근 뉴스 및 업데이트

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

Nov 27

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Nov 09

Recent updates

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

Nov 27

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Nov 09

J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price

Sep 24

Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation

Aug 15

J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 11

These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well

Jun 28

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

Apr 19

J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

Feb 09

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

Dec 22

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

Nov 29

J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25

Aug 03

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50

Feb 11

Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?

Dec 03

A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Sep 21

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly

Aug 03

Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Jun 15

Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?

Mar 29

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50

Feb 16

주주 수익률

	JBCHEPHARM	IN Pharmaceuticals	IN 마켓
7D	-0.5%	1.9%	2.9%
1Y	18.8%	42.6%	27.9%

수익률 대 산업: JBCHEPHARM 지난 1년 동안 42.6 %를 반환한 Indian Pharmaceuticals 업계보다 저조한 성과를 냈습니다.

수익률 대 시장: JBCHEPHARM 지난 1년 동안 27.9 %를 반환한 Indian 시장보다 저조한 성과를 냈습니다.

가격 변동성

Is JBCHEPHARM's price volatile compared to industry and market?
JBCHEPHARM volatility
JBCHEPHARM Average Weekly Movement	4.1%
Pharmaceuticals Industry Average Movement	6.1%
Market Average Movement	6.1%
10% most volatile stocks in IN Market	9.0%
10% least volatile stocks in IN Market	4.0%

안정적인 주가: JBCHEPHARM 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: JBCHEPHARM 의 주간 변동성( 4% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립	직원	CEO	웹사이트
1976	5,311	Nikhil Chopra	www.jbpharma.com

J. B. Chemicals & Pharmaceuticals Limited는 인도 및 전 세계에서 의약품 제제, 약초 치료제, 활성 의약품 성분(API)을 제조 및 판매합니다. 이 회사의 API 제품 포트폴리오에는 디클로페낙 나트륨, 디에틸아민, 산, 칼륨, 니페디핀, 아테놀롤, 실니디핀, 시프로플록사신, 세티리진, 메클리진 HCI 등이 있습니다. 또한 정제, 로젠지, 주사제, 젤, 크림, 연고, 액상 허브 시럽, 콜드럽, 안약, 트로치, 캡슐 등의 제형과 연질 중심, 분말, 약제, 허브 로젠지 등 다양한 약품 제형을 제공합니다.

J. B. Chemicals & Pharmaceuticals Limited 기본 사항 요약

J. B. Chemicals & Pharmaceuticals 의 수익과 매출은 시가총액과 어떻게 비교하나요?
JBCHEPHARM 기본 통계
시가총액	₹269.49b
수익(TTM)	₹6.11b
수익(TTM)	₹37.11b

44.1x

P/E 비율

7.3x

P/S 비율

JBCHEPHARM 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
JBCHEPHARM 손익 계산서(TTM)
수익	₹37.11b
수익 비용	₹12.84b
총 이익	₹24.27b
기타 비용	₹18.16b
수익	₹6.11b

최근 보고된 수익

Sep 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)	39.35
총 마진	65.40%
순이익 마진	16.47%
부채/자본 비율	2.5%

JBCHEPHARM 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

배당금

0.8%

현재 배당 수익률

17%

지급 비율

JBCHEPHARM 주식 개요

보상

위험 분석

J. B. Chemicals & Pharmaceuticals Limited 경쟁사

NSEI:GLAND

₹286.3b

NSEI:AJANTPHARM

₹377.5b

NSEI:IPCALAB

₹391.4b

BSE:524558

₹214.1b

가격 내역 및 성능

최근 뉴스 및 업데이트

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Second quarter 2025 earnings: EPS exceeds analyst expectations

J. B. Chemicals & Pharmaceuticals Limited to Report Q2, 2025 Results on Nov 06, 2024

Vice President of HR & Administration recently sold ₹5.8m worth of stock

Insider recently sold ₹2.1m worth of stock

Recent updates

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Second quarter 2025 earnings: EPS exceeds analyst expectations

J. B. Chemicals & Pharmaceuticals Limited to Report Q2, 2025 Results on Nov 06, 2024

Vice President of HR & Administration recently sold ₹5.8m worth of stock

Insider recently sold ₹2.1m worth of stock

J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price

Alkem Reportedly Joins $3 Billion Race for JB Chem as Torrent Pauses Talks

Insider recently sold ₹7.2m worth of stock

Key Executive recently sold ₹1.4m worth of stock

J. B. Chemicals & Pharmaceuticals Limited Approves Final Dividend for the Year Ended March 31, 2024

Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation

Torrent Pharma Reportedly is Said to Seek Raising $3 Billion for KKR's Stake in JB Chemicals

J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Torrent Pharmaceuticals Reportedly in Talks to Acquire KKR’s Stake in JB Chemicals

Full year 2024 earnings: EPS misses analyst expectations

Final dividend of ₹6.75 announced

J. B. Chemicals & Pharmaceuticals Limited to Report Q1, 2025 Results on Aug 08, 2024

Insider recently sold ₹876k worth of stock

J. B. Chemicals & Pharmaceuticals Limited, Annual General Meeting, Aug 21, 2024

These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well

Insider recently sold ₹1.1m worth of stock

Full year 2024 earnings: EPS misses analyst expectations

J. B. Chemicals & Pharmaceuticals Limited Recommends Final Dividend for the Year 2023-2024

J. B. Chemicals & Pharmaceuticals Limited to Report Q4, 2024 Results on May 17, 2024

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

President of Global Business recently sold ₹5.6m worth of stock

Insider recently sold ₹3.2m worth of stock

Insider recently sold ₹2.3m worth of stock

KKR Reportedly Considers Selling Controlling Stake in JB Pharma

President of India Business recently sold ₹6.8m worth of stock

Price target increased by 7.1% to ₹1,870

Upcoming dividend of ₹5.50 per share at 0.6% yield

J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

Dividend of ₹5.50 announced

J. B. Chemicals & Pharmaceuticals Limited Declares Interim Dividend for Financial Year 2023-24

J. B. Chemicals & Pharmaceuticals Limited to Report Q3, 2024 Results on Feb 06, 2024

Price target increased by 8.4% to ₹1,677

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

Less than half of directors are independent

J. B. Chemicals & Pharmaceuticals Limited Appoints Akshay Tanna as an Additional Director

Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

J. B. Chemicals & Pharmaceuticals Limited to Report Q2, 2024 Results on Nov 07, 2023

CEO & Whole-Time Director recently sold ₹35m worth of stock

J. B. Chemicals & Pharmaceuticals Limited Announces Cessation of Lakshay Kataria, Chief Financial Officer and Key Managerial Personnel, Effective November 30, 2023

CEO & Whole-Time Director recently sold ₹40m worth of stock

J. B. Chemicals & Pharmaceuticals Limited Approves Final Dividend for the Year Ended March 31, 2023

J.B. Chemicals & Pharmaceuticals Limited Announces Abbreviated New Drug Application Approval by US FDA

CEO & Whole-Time Director recently sold ₹40m worth of stock

Price target increased by 8.1% to ₹2,556

Upcoming dividend of ₹9.25 per share at 0.7% yield

J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25

J. B. Chemicals & Pharmaceuticals Limited to Report Q1, 2024 Results on Aug 09, 2023

Full year 2023 earnings: EPS misses analyst expectations

CEO & Whole-Time Director recently sold ₹32m worth of stock

J. B. Chemicals & Pharmaceuticals Limited Recommends Final Dividend for the Year 2022-2023

Full year 2023 earnings: EPS misses analyst expectations

Insider recently sold ₹1.2m worth of stock